The Foundation for Research and Technology – Hellas (FORTH) was founded in 1983.
It is the premier multidisciplinary research institution in Greece with well-organized facilities, highly qualified personnel and a reputation as a top-level research institution worldwide.
IMBB researchers reveal that DNA damage in tissue-infiltrating macrophages triggers an exosome-based metabolic reprogramming leading to chronic inflammation.
Research carried out at the Institute of Molecular Biology and Biotechnology (IMBB) of FORTH, provides evidence that persistent DNA damage triggers an exosome-based, metabolic reprogramming that leads to chronic inflammation and tissue pathology in DNA repair-deficient progeroid syndromes and likely also during aging.
"Generation of optical Schrödinger “cat” states in intense laser-matter interactions" was published in Nature Physics.
In a theoretical and experimental study published in Nature Physics, an international team of researchers led by Prof. Maciej Lewenstein (ICFO -Spain) and Dr. Paraskevas Tzallas (FORTH-Greece), demonstrates the generation of highly non-classical states of light in intense laser–atom interactions.
FORTH/ICE-HT (www.iceht.forth.gr) has created the “Stratis V. Sotirchos Lectureship” to honor the memory of one of its most distinguished Researchers, Professor Stratis V. Sotirchos. This Award is supported by the “Stratis V. Sotirchos Trust Fund”, which has been created from donations by friends and colleagues.
The IMBB Director, Professor John Vontas, selected as a Highly Cited Researcher by WoS, for the year 2021
The director of the Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology-Hellas, has been named as one of the most cited researchers worldwide, according to this year’s “Highly Cited Researchers” list from Clarivate, based on the widely recognised Web of Science database.
The Foundation for Research and Technology-Hellas (FORTH) and its Institutes have been made available to the State and Public Health Authorities, in order to contribute to the common effort to address the pandemic of COVID-19, with their top-level infrastructure and expertise.